|
US2020199172A1
|
|
Natural and synthetic compounds for treating cancer and other diseases
|
|
US2019256543A1
|
|
Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
|
|
US2017267714A1
|
|
Natural and synthetic compounds for treating cancer and other diseases
|
|
US2016354397A1
|
|
Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
|
|
AU2015200182A1
|
|
Blocking the metastasis of cancer cells and the uses of new compounds as antiprotozoal agents
|
|
US2014322810A1
|
|
Natural and synthetic compounds for treating cancer and other diseases
|
|
US2013338089A1
|
|
Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
|
|
CN103857399A
|
|
New natural and synthetic compounds for treating cancer and other diseases
|
|
KR20130136437A
|
|
New compounds for treating cancer and other diseases
|
|
CA2805136A1
|
|
New compounds for treating cancer and other diseases
|
|
WO2011009032A1
|
|
Inhibiting the invasion and metastasis of cancer cells
|
|
AU2009226063A1
|
|
Blocking the metastasis of cancer cells and the uses of new compounds thereof
|
|
AU2008244648A1
|
|
Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
|
|
CN101553497A
|
|
Anti-tumor compounds for inhibiting cancer growth
|
|
US2006122129A1
|
|
Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
|
|
KR20070113185A
|
|
Anti-tumor compounds with angeloyl groups
|
|
NZ554037A
|
|
Pentacyclic anti-tumour compounds with angeloyl groups and optional sugar moieties
|
|
AU2005282437A1
|
|
Anti-tumor compounds with angeloyl groups
|
|
CN101123880A
|
|
Anti-tumor compounds with angeloyl groups
|
|
TW200616648A
|
|
New anti - cancer compound
|
